Non-small-cell lung cancer--stalemate or progress?
暂无分享,去创建一个
[1] S. Adak,et al. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group. , 2000, The New England journal of medicine.
[2] T. Nakano,et al. Phase II study of irinotecan (CPT-11) combined with etoposide (VP-16) for previously untreated extensive stage small cell lung cancer (ES-SCLC) , 2000 .
[3] J. Minna,et al. Molecular pathogenesis of lung cancer. , 1999, The Journal of thoracic and cardiovascular surgery.
[4] J. Padilla,et al. Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial. , 1999, Lung cancer.
[5] F. Khuri,et al. Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. , 1999, Journal of the National Cancer Institute.
[6] J. Roth,et al. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. , 1998, Lung cancer.
[7] S. Anthony,et al. Chemotherapy plus Radiotherapy Compared with Radiotherapy Alone in the Treatment of Locally Advanced, Unresectable, Non-Small-Cell Lung Cancer , 1996, Annals of Internal Medicine.
[8] J. Pignon,et al. Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer: A meta‐analysis , 1996, Cancer.
[9] F. Shepherd. Induction chemotherapy for locally advanced non-small cell lung cancer. , 1993, The Annals of thoracic surgery.